Concerns are growing that delays in financing critical Ebola clinical trials could hamper efforts to contain the rapidly expanding outbreak in the Democratic Republic of Congo (DRC)
The Africa Centres for Disease Control and Prevention (Africa CDC) is warning that an urgent USD18 million funding gap is jeopardising key elements of the emergency response.
The warning comes days after global health partners unveiled an ambitious strategy aimed at ensuring vaccines and treatments for rare Ebola strains are developed before rather than during, future outbreaks.
Facts First
This story continues on The Standard INSiDER. Subscribe now for unfiltered journalism that holds power to account.
Already have an account? Login
The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.